Amlodipine Besylate
Product Images NDC 12634-562

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 12634-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotheca Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (562 71)

Amlodipine Besylate 5 mg tablet packaging label from Apotheca Inc., containing 30 tablets. The label includes the product NDC 12634-562-71 and states the tablets are to be dispensed in a tight, light-resistant container with a child-resistant closure. The label also provides storage instructions, directions for use, and contact information for medical advice.*

FDA Label Image

Chemical Structure (75496a09 3e64 4469 8456 4506706d3e83 01)

Chemical structure of amlodipine besylate, an active ingredient shown with its molecular components including chlorine, nitrogen, oxygen, sulfur, and carbon atoms forming its characteristic rings and side groups.*

FDA Label Image

Kaplan-meier Analysis Of Composite Clinical Outcomes For Amlodipine Versus Placebo Kaplan-meier Analysis Of Composite Clinical Outcomes For Amlodipine Versus Placebo Figure-02 (75496a09 3e64 4469 8456 4506706d3e83 02)

A line graph depicting event rate over time (months) comparing Amlodipine to placebo. The graph includes two curves, one labeled "Amlodipine" and the other "Placebo," showing event rates increasing over a 24-month period. Number at risk values are provided along the x-axis, and a statistical inset includes a p-value of 0.003, hazard ratio of 0.691, and 95% confidence interval (0.54, 0.88).*

FDA Label Image

Figure-03 (75496a09 3e64 4469 8456 4506706d3e83 03)

A forest plot chart depicting hazard ratios with 95% confidence intervals comparing Amlodipine to placebo across multiple patient subgroups, including overall patients, age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The vertical dashed line indicates no effect (hazard ratio of 1).*

FDA Label Image

Company Logo (75496a09 3e64 4469 8456 4506706d3e83 04)

FDA Label Image

Company Logo (75496a09 3e64 4469 8456 4506706d3e83 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.